Evidence map›Paper›PMID 41757964›Full record

ArticleJournal of virology2026

The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection.

Mohammed Nooruzzaman, Salman L Butt, Ruchi Rani, Chengjin Ye, Andrew D Miller, Luis Martinez-Sobrido, Ying Fang, Diego G Diel

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammed NooruzzamanDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-9358-1494
Salman L ButtDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-4565-0125
Ruchi RaniDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0001-7388-6912
Chengjin YeTexas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0002-1934-9494
Andrew D MillerDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Luis Martinez-SobridoTexas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0001-7084-0804
Ying FangDepartment of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0002-3289-3654
Diego G DielDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0003-3237-8940

Funding

Novel diagnostic tools and animal model system for study human/animal interface of COVID-19R01AI166791 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI DIEL, DIEGO G, FANG, YING · 2021 to 2024
$3.1M
NIAID NIH HHS R01 AI166791NIH HHS R01AI166791-01
6 · The paper itself

Abstract

In this study, the infection dynamics, replication, and pathogenicity of a recombinant virus containing a deletion of ORF6 (rWA1ΔORF6) on the backbone of the highly virulent SARS-CoV-2 WA1 virus (rWA1) were investigated and compared to the parental rWA1 virus. While both rWA1 and rWA1ΔORF6 viruses replicated efficiently in cultured cells, the rWA1ΔORF6 virus produced smaller plaques, suggesting reduced cell-to-cell spread. Luciferase reporter assays revealed immune-suppressing effects of ORF6 on interferon (IFN) and nuclear factor kappa B (NF-κB) signaling pathways. Pathogenesis assessment in cats revealed that animals inoculated with rWA1 were lethargic and presented with fever on days 2 and 4 post-infection (pi), whereas rWA1ΔORF6-inoculated animals developed subclinical infection. Additionally, animals inoculated with rWA1ΔORF6 presented reduced infectious virus shedding in nasal and oral secretions and broncho-alveolar lavage fluid when compared with the rWA1-inoculated cats. Similarly, the rWA1ΔORF6-inoculated cats presented reduced virus replication in the respiratory tract as evidenced by lower viral loads and reduced lung inflammation on days 3 and 5 pi when compared to rWA1-inoculated animals. Host gene transcriptomic analysis revealed distinct differentially expressed gene (DEG) profiles in the nasal turbinate of animals infected with rWA1 when compared to rWA1ΔORF6. Importantly, type I IFN signaling was significantly upregulated in rWA1ΔORF6-infected cats when compared to rWA1-inoculated animals, which could potentially contribute to the reduced replication of rWA1ΔORF6 in the upper and lower respiratory tracts of infected animals. Collectively, these results demonstrate that the SARS-CoV-2 ORF6 is an important virulence determinant of the virus, contributing to the modulation of host antiviral immune responses.IMPORTANCESARS-CoV-2 encodes several proteins that inhibit host IFN responses. The accessory protein ORF6 antagonizes IFN signaling by blocking the nucleocytoplasmic trafficking of key transcription factors. In this study, we showed that ORF6 plays an important role in SARS-CoV-2 pathogenesis. While both rWA1 and rWA1ΔORF6 viruses replicated efficiently in cell culture, the rWA1ΔORF6 presented impaired cell-to-cell spread and reduced innate immune inhibition compared to the parental rWA1. A pathogenesis study in the feline model revealed an attenuated phenotype of the rWA1ΔORF6, indicating that ORF6 is a major virulence determinant of SARS-CoV-2.

Indexed as

COVID-19SARS-CoV-2Viral ProteinsAnimalsCatsChlorocebus aethiopsDisease Models, AnimalHumansInterferonsNF-kappa BSignal TransductionVero CellsVirulenceVirus ReplicationVirus SheddingInterferonsNF-kappa BORF6 protein, SARS-CoV-2Viral ProteinsORF6pathogenesisSARS-CoV-2virulence

Identifiers

PMID41757964
PMCPMC13011341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.